Clinically Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) with Related Factors | Abstract Continue ReadingClinically Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) with Related Factors | Abstract
Recent Research Development of Imeglimin as Oral Hypoglycemic Agent (OHA) | Abstract Continue ReadingRecent Research Development of Imeglimin as Oral Hypoglycemic Agent (OHA) | Abstract
Detail Measurement of Pre-Prandial and Post-Prandial Blood Glucose during Imeglimin (Twymeeg) Treatment | Abstract Continue ReadingDetail Measurement of Pre-Prandial and Post-Prandial Blood Glucose during Imeglimin (Twymeeg) Treatment | Abstract
Clinical Efficacy of Imeglimin (Twymeeg) for Elderly Patient with Type 2 Diabetes Mellitus (T2DM) | Abstract Continue ReadingClinical Efficacy of Imeglimin (Twymeeg) for Elderly Patient with Type 2 Diabetes Mellitus (T2DM) | Abstract
